NCT03839654View on ClinicalTrials.gov

Loop Gain in the Reversion of OSA Treated by Either CPAP or Cardiac Valve Replacement

NAUnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2020

Primary Completion Date

June 30, 2023

Study Completion Date

December 31, 2023

Conditions
Obstructive Sleep Apnea of AdultHeart Valve Diseases
Interventions
DEVICE

continuous positive airway pressure

The CPAP treatment group received both baseline medicine and CPAP treatment for 7 days preoperatively.

Trial Locations (1)

210029

RECRUITING

the First Affiliated Hospital of Nanjing Medical University, Nanjing

Sponsors
All Listed Sponsors
lead

Nanjing Medical University

OTHER

NCT03839654 - Loop Gain in the Reversion of OSA Treated by Either CPAP or Cardiac Valve Replacement | Biotech Hunter | Biotech Hunter